(Q39109978)

9 September 2017

Chronic inflammation-derived nitric oxide causes conversion of human colonic adenoma cells into adenocarcinoma cells (English)

1 reference

9 September 2017

1 reference

Hiroshi Tazawa

1

0 references

Futoshi Okada

object named as

Futoshi Okada

13

0 references

author name string

Tokuichi Kawaguchi

2

1 reference

9 September 2017

Tokushige Kobayashi

3

1 reference

9 September 2017

Yasuhiro Kuramitsu

4

1 reference

9 September 2017

Sayori Wada

5

1 reference

9 September 2017

Yoshiko Satomi

6

1 reference

9 September 2017

Hoyoku Nishino

7

1 reference

9 September 2017

Masanobu Kobayashi

8

1 reference

9 September 2017

Yusuke Kanda

9

1 reference

9 September 2017

Mitsuhiko Osaki

10

1 reference

9 September 2017

Tomoyuki Kitagawa

11

1 reference

9 September 2017

Masuo Hosokawa

12

1 reference

9 September 2017

language of work or name

English

0 references

publication date

13 August 2013

1 reference

Experimental Cell Research

9 September 2017

1 reference

9 September 2017

319

1 reference

9 September 2017

18

1 reference

9 September 2017

2835-2844

1 reference

The yin and yang of nitric oxide in cancer progression.

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Cell signaling mediated by nitrated cyclic guanine nucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Role of nitric oxide in carcinogenesis and tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

The multifaceted roles of nitric oxide in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Nitric oxide synthases: which, where, how, and why?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Pathologic features of Hashimoto's-associated papillary thyroid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Nitrative DNA damage in inflammation and its possible role in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Nitric oxide signaling in colon cancer chemoprevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

The critical role of nitric oxide signaling, via protein S-guanylation and nitrated cyclic GMP, in the antioxidant adaptive response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Protein S-guanylation by the biological signal 8-nitroguanosine 3',5'-cyclic monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Nitric oxide synthase inhibition promotes carcinogen-induced preneoplastic changes in the colon of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Establishment and Characterization of an Epithelial Cell Line with Quasi-normal Chromosomes from a Tubular Adenoma of a Familial Polyposis Coli Patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Acquired multicellular-mediated resistance to alkylating agents in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Nitric oxide synthase activity in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Selective expression of inducible nitric oxide synthase in human prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Inflammatory Bowel Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

RAGE: a new pleiotropic antagonistic gene?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Persistent oxidative stress in human colorectal carcinoma, but not in adenoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.08.006

10.1016/J.YEXCR.2013.08.006

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference